Antiretroviral Therapy Immune Function Reinstallation in HIV-Infection in Sub Sahara Africa Population
Asian Hematology Research Journal,
Aims: To access antiretroviral therapy immune function reinstallation in HIV-infection in a sub-Sahara Africa population.
Study Design: The study was carried out in HIV seronegative healthy young (20-35 years) adults (CTRL), HIV Seropositive ART-Naive (20-35 years) young adults (Naïve) and HIV Seropositive on Anti-retroviral therapy (ART) aged 20-35 years old.
Place and Duration of Study: One hundred and fifty subjects were used for the study. One hundred (100) are HIV seropositive individuals, 50 on ART and 50 ART-Naive attending the Federal Medical Centre Owerri between August and December 2020. Fifty (50) healthy younger adults of the same age range served as controls in this study.
Methodology: EDTA and plain vacutainers were used to collect Venous blood from each participant. The following parameters were determined in the subjects: Viral load, CD4+, CD8+, CD4+/CD8+ ratio was calculated and CD57+ measured, Erythrocyte Sedimentation rate (ESR), and C-reactive protein (CRP) concentrations were also determined in subjects. The data generated were analysed by a one-way analysis of variances (ANOVA) using Statistical Package for Social Sciences (SPSS) version 21.
Results: The result of the study showed that Naïve individuals had a mean viral load of 41.54±13.39 copies/ml (IQR12-18) while subjects on ART had a significantly (p<0.05) lower mean viral load value of 22.26±11.31 (IQR8-54). CD4+ count obtained was 335.46 ± 76.75, 482.80 ± 88.69 and 846.08 ± 231.47cells/mm3 in NAIVE, ART and Control subjects respectively. CD8+ count obtained was 604.34 ± 126.09, 441.48 ± 94.42 and 376.86 ± 51.17 cells/mm3 in NAÏVE, ART and CTRL,respectively. Our result showed that HIV infection significantly (P<0.05) decreased CD4+/CD8+ ratio. CD57+ counts in ART treated subjects were found to be improved by treatment. CD4+ count correlated positively with viral load in NAÏVE (r = 0.799) and in ART subjects (r = 0.809). ART-NAÏVE, ART and CTRL subjects had IFN-γ concentrations of 186.44 ± 38.67, 161.83 ± 37.34 and 133.73 ± 25.97 pg/ml respectively. ESR was significantly (P<0.05) elevated in HIV seropositive subjects (NAÏVE and ART)(49.16 ± 5.49mm/hr and 24.12 ±2.88mm/hr) when compared to CTRL (7.66 ± 0.61 mm/hr). ART treatment resulted in a significant (P<0.05) decrease in ESR among seropositives. CRP concentration was significantly (P<0.05) increased in NAÏVE when compared to CTRL and subjects.
Conclusion: We conclude that Antiretroviral therapy in HIV-seropositive individuals acts to reinstall immune function and normalize fuction. Although immune function was not completely normalized, it was closer to normal than ART-naïve person whose immune function was largely compromised.
- Viral load
- immune response normalization
- CD4 /CD8
- immune function
How to Cite
Andrea L, Georgios G, Natasha L, Marie-Renee BL, Olivier D, John S, et al. Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Clin Infect Dis. 2016; 62(12):1595-1603.
Alisi PNC, Jeremiah ZA, EZE EM, Ibegbulam EO, Oxidative Stress Status and Antioxidant Homeostasis in HIV-infection and Ageing are Tightly Logistic in Humans. International Journal of Research and Reports in Hematolgy. 2021;4(2):1-11.
National Agency for the Control of AIDS (NACA). Federal Republic of Nigeria Country Progress Report: Nigeria GARPR 2019. Abuja, Nigeria: NACA; 2019. Available:http://www.unaids.org/sites/default/files/country/documents/NGA_narrative_report_2019.pdf. Published 2019.
Accessed March 2019.
National Committee for Clinical Standards. Reference Procedure for Erythrocyte Sedimentation Rate tested H2-A3 Villanova, Pa: NCCLS; 1993.
Saul J, Erwin J, Bruce JC, Peters B. Etnnic and demographic variation in HIV/AIDS presentation at two London referral centres 1995-9. Sexually Transmitted Infection. 2000;76(3):215.
Nwokedi EE, Ochicha O, Mohammed A Z, Saddiq NM, Baseline CD4 lymphocyte count among HIV patients in Kano, Northern Nigeria. African Journal of Health Sciences. 2007;14(3): 212-215.
Fevrier M, Dorgham K, Rebollo A, CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: Role of apoptosis. Viruses. 2011;3(5): 586-612.
Ronsholt FF, Ullum H, Katzenstein TL, Gerstoft J, Ostrowski SR. T-cell subset distribution in HIV-1-infected patients after 12 years of treatment-induced viremic suppression. Journal of Acquired Immune Deficiency Syndrome. 2012; 61:270–280.
Robinson O, Obianime AW, Aprioku J, Igbiks Tamuno I. Immunological and Hematological Profile of HIV Patients on Anti-retroviral Therapy in Port Harcourt, Rivers State, Nigeria. International Blood Research & Reviews. 2017;7(4):1-12.
Collins DR, Galha GD, Walker BD. CD8+ T cells in HIV control, cure and prevention. Nature Reviews Immunology. 2020;20: 471–482.
Helleberg M, Kronborg G, Ullum H, Ryder LP, Obel N, Gerstoft J, Course and clinical significance of CD8+ T-cell counts in a large cohort of HIV-infected individuals. Journal of Infectious Disease. 2015;211:1726–1734.
Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. Journal of Clinical Investigation. 1995;95:2061–2066.
Chen J, Rappsilber J, Chiang YC, Russell P, Mann M, Dennis CI. Purification and Characterization of the 1.0 MDa CCR4-NOT complex identifies two novel components of the complex. Journal of Molecular Biology. 2001;314(4): 683-694
Valiathan R, Ashman M, Asthana D, Effects of ageing on the immune system: infants to elderly. Scandinavian Journal of Immunology. 2016;83(4):255-266.
Mutoh Y, Nishijima T, Inaba Y, Tanaka N, Kikuchi Y, Gatanaga H, Oka S, Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Human Immunodeficiency Virus Infected Patients on Long-term Antiretroviral Therapy With Suppressed Viremia. Clinical Infectious Diseases. 2018;67(6):927–933.
Davey-Mendez T, Napravnik S, Zakharova O, Kuruc J, Gay C, Hicks CB, Mcgee KS, Eron JJ, Acute HIV Infection and CD4/CD8 Ratio Normalization after Antiretroviral Therapy Initiation. Journal of Acquired Immune Deficiency Syndrome. 2018;79(4):510-518.
Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical Infectious Disease. 2007;44:441–446.
Kelley CF, Kitchen CM, Hunt PW. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical Infection Disease. 2009;48:787–94.
Sze DM, Giesajtis G, Brown RD, Raitakari M, Gibson J, Ho J. Clonal cytotoxic Tcells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood. 2001;98(9):2817–2827.
Vallejo AN. CD28 extinction in human Tcells: altered functions and the pro- gram of T-cell senescence. Immunological Reviews. 2005;205:158–169.
Focosi D, Bestagno M, Burrone O, Petrini M, CD57+ T lymphocytes and functional immunedeficiency. Journal of Leukocyte Biology. 2010;87(1):107–116.
Abstract View: 57 times
PDF Download: 40 times